The fundamentals of Novo and Lilly do look robust, but it is always wise to avoid putting all of your eggs in one basket.
Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) announced plans to invest approximately $1.20 billion (8.5 billion ...
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback